BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36255392)

  • 1. Microfluidic-assisted biomineralization of CRISPR/Cas9 in near-infrared responsive metal-organic frameworks for programmable gene-editing.
    Xu X; Liu C; Wang S; Mäkilä E; Wang J; Koivisto O; Zhou J; Rosenholm JM; Shu Y; Zhang H
    Nanoscale; 2022 Nov; 14(42):15832-15844. PubMed ID: 36255392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rationally Designed Semiconducting Polymer Brush for NIR-II Imaging-Guided Light-Triggered Remote Control of CRISPR/Cas9 Genome Editing.
    Li L; Yang Z; Zhu S; He L; Fan W; Tang W; Zou J; Shen Z; Zhang M; Tang L; Dai Y; Niu G; Hu S; Chen X
    Adv Mater; 2019 May; 31(21):e1901187. PubMed ID: 30957918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries.
    Wang Y; Shahi PK; Xie R; Zhang H; Abdeen AA; Yodsanit N; Ma Z; Saha K; Pattnaik BR; Gong S
    J Control Release; 2020 Aug; 324():194-203. PubMed ID: 32380204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationally designed nanoparticle delivery of Cas9 ribonucleoprotein for effective gene editing.
    Chae SY; Jeong E; Kang S; Yim Y; Kim JS; Min DH
    J Control Release; 2022 May; 345():108-119. PubMed ID: 35247491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologically produced and metal-organic framework delivered dual-cut CRISPR/Cas9 system for efficient gene editing and sensitized cancer therapy.
    Yu J; Tang M; Zhou Z; Wei Z; Wan F; Hou S; Li Q; Li Y; Tian L
    Acta Biomater; 2024 Apr; 178():296-306. PubMed ID: 38417646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Packaging and Uncoating of CRISPR/Cas Ribonucleoproteins for Efficient Gene Editing with Viral and Non-Viral Extracellular Nanoparticles.
    Mazurov D; Ramadan L; Kruglova N
    Viruses; 2023 Mar; 15(3):. PubMed ID: 36992399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small extracellular vesicle-mediated CRISPR-Cas9 RNP delivery for cardiac-specific genome editing.
    Mun D; Kang JY; Kim H; Yun N; Joung B
    J Control Release; 2024 Jun; 370():798-810. PubMed ID: 38754633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
    Chen X; Chen Y; Xin H; Wan T; Ping Y
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects.
    Deng S; Li X; Liu S; Chen J; Li M; Chew SY; Leong KW; Cheng D
    Sci Adv; 2020 Jul; 6(29):eabb4005. PubMed ID: 32832641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
    Im SH; Jang M; Park JH; Chung HJ
    J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
    Wang R; Graham S; Gao L; Tam J; Levesque MC
    Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation.
    Campbell LA; Richie CT; Maggirwar NS; Harvey BK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):565-577. PubMed ID: 31172397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
    Li X; Shi W; Geng LZ; Xu JP
    Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells.
    Han AR; Shin HR; Kwon J; Lee SB; Lee SE; Kim EY; Kweon J; Chang EJ; Kim Y; Kim SW
    BMB Rep; 2024 Jan; 57(1):60-65. PubMed ID: 38053293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
    Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
    Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy.
    Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y
    J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
    Bykonya AG; Lavrov AV; Smirnikhina SA
    Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.